Topic: AS06-Prognosis/AS06b-Predictive factors of response to treatment: AUGMENTED ACTIVITY OF THE ALVOCIDIB AND 5-AZACYTIDINE COMBINATION IN MYELODYSPLASTIC NEOPLASMS IS ASSOCIATED WITH THE PRESENCE OF ASXL1 MUTATIONS. (May 2023)

• Record Type: Journal Article
• Authors: Ryabov, V.; Xu, Q.; Schmitt, N.; Streuer, A.; Ge, G.; Bolanos, L.; Wunderlich, M.; Jann, J.-C.; Wein, A.; Altrock, E.; Mukherjee, S.; Ali, A.M.; Rapp, F.; Nowak, V.; Weimer, N.; Obländer, J.; Palme, I.; Göl, M.; Jawhar, A.; Darwich, A.; Wuchter, P.; Weiss, C.; Raza, A.; Foulks, J.M.; Starczynowski, D.T.; Yang, F.-C.; Metzgeroth, G.; Steiner, L.; Jawhar, M.; Hofmann, W.-K.; Nowak, D.;
• Is Part Of: Leukemia research. Volume 128(2023)Supplement
• Publication Date: 2023-05
• Subjects: Leukemia -- Periodicals; Leukemia -- Periodicals; Leucémie -- Périodiques; Leukemia; Periodicals; Electronic journals; Electronic journals; 616.9941905
• DOI: 10.1016/j.leukres.2023.107238
• Languages: English
• ISSNs: 0145-2126